IL2 and hepatocellular carcinoma: A number of studies demonstrating FUZHENG Yiliu’s effects on hepatoma cells have been published showing an increase in CD3+, CD4+ and NK cells in peripheral blood with an increase in IL-2 and TNF-α, thus inhibiting hepatocellular cancer proliferation (Cao et al., 2011; Cao et al., 2012).